Chemotherapy Induced Nausea And Vomiting Treatment Market
Chemotherapy Induced Nausea And Vomiting Treatment Market Analysis, By Drugs Type (5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoid Receptor Agonist, and Others), By Emetogenic Risk (Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), and Low Emetogenic Chemotherapy (LEC)), By Form (Injectable, Oral, and Transdermal Patches), By Distribution Channel (Hospitals, Cancer Research Institutes, Retail Pharmacies, Online Pharmacies, and Drug Stores), and By Region - Market Insights 2024 to 2034
Analysis of Chemotherapy Induced Nausea And Vomiting Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT6867MR
- 02 Sep 2024
- Healthcare
- 170 Pages
- 40 Tables
- 40 Figures
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 5.1. Drugs Type
- 5.2. Emetogenic Risk
- 5.3. Form
- 5.4. Distribution Channel
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drugs Type
- 6.1. 5-HT3 Receptor Antagonists
- 6.2. Neurokinin-1 Receptor Antagonists
- 6.3. Corticosteroids
- 6.4. Cannabinoid Receptor Agonist
- 6.5. Others
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Emetogenic Risk
- 7.1. Highly Emetogenic Chemotherapy (HEC)
- 7.2. Moderately Emetogenic Chemotherapy (MEC)
- 7.3. Low Emetogenic Chemotherapy (LEC)
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Form
- 8.1. Injectable
- 8.2. Oral
- 8.3. Transdermal Patches
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
- 9.1. Hospitals
- 9.2. Cancer Research Institutes
- 9.3. Retail Pharmacies
- 9.4. Online Pharmacies
- 9.5. Drug Stores
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
- 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. Sales Forecast 2024 to 2034 by Drugs Type, Emetogenic Risk, Form, and Distribution Channel for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Kyowa Kirin, Inc.
- 20.2. Pfizer Inc.
- 20.3. GlaxoSmithKline plc.
- 20.4. AbbVie Inc. (Allergan plc)
- 20.5. Merck & Co., Inc.
- 20.6. Bausch Health Companies Inc.
- 20.7. Novartis AG
- 20.8. Ono Pharmaceutical Co., Ltd.
- 20.9. Camurus AB
- 20.10. Heron Therapeutics, Inc.
- 20.11. Other Prominent Players
- 21. Assumptions & Acronyms Used
- 22. Research Methodology
List Of Table
Table 01: Global Market US$ Mn Forecast by Region, 2019 to 2034
Table 02: Global Market US$ Mn Forecast by Drugs Type, 2019 to 2034
Table 03: Global Market US$ Mn Forecast by Emetogenic Risk, 2019 to 2034
Table 04: Global Market US$ Mn Forecast by Form, 2019 to 2034
Table 05: Global Market US$ Mn Forecast by Distribution Channel, 2019 to 2034
Table 06: North America Market US$ Mn Forecast by Country, 2019 to 2034
Table 07: North America Market US$ Mn Forecast by Drugs Type, 2019 to 2034
Table 08: North America Market US$ Mn Forecast by Emetogenic Risk, 2019 to 2034
Table 09: North America Market US$ Mn Forecast by Form, 2019 to 2034
Table 10: North America Market US$ Mn Forecast by Distribution Channel, 2019 to 2034
Table 11: Latin America Market US$ Mn Forecast by Country, 2019 to 2034
Table 12: Latin America Market US$ Mn Forecast by Drugs Type, 2019 to 2034
Table 13: Latin America Market US$ Mn Forecast by Emetogenic Risk, 2019 to 2034
Table 14: Latin America Market US$ Mn Forecast by Form, 2019 to 2034
Table 15: Latin America Market US$ Mn Forecast by Distribution Channel, 2019 to 2034
Table 16: Western Europe Market US$ Mn Forecast by Country, 2019 to 2034
Table 17: Western Europe Market US$ Mn Forecast by Drugs Type, 2019 to 2034
Table 18: Western Europe Market US$ Mn Forecast by Emetogenic Risk, 2019 to 2034
Table 19: Western Europe Market US$ Mn Forecast by Form, 2019 to 2034
Table 20: Western Europe Market US$ Mn Forecast by Distribution Channel, 2019 to 2034
Table 21: Eastern Europe Market US$ Mn Forecast by Country, 2019 to 2034
Table 22: Eastern Europe Market US$ Mn Forecast by Drugs Type, 2019 to 2034
Table 23: Eastern Europe Market US$ Mn Forecast by Emetogenic Risk, 2019 to 2034
Table 24: Eastern Europe Market US$ Mn Forecast by Form, 2019 to 2034
Table 25: Eastern Europe Market US$ Mn Forecast by Distribution Channel, 2019 to 2034
Table 26: East Asia Market US$ Mn Forecast by Country, 2019 to 2034
Table 27: East Asia Market US$ Mn Forecast by Drugs Type, 2019 to 2034
Table 28: East Asia Market US$ Mn Forecast by Emetogenic Risk, 2019 to 2034
Table 29: East Asia Market US$ Mn Forecast by Form, 2019 to 2034
Table 30: East Asia Market US$ Mn Forecast by Distribution Channel, 2019 to 2034
Table 31: South Asia & Pacific Market US$ Mn Forecast by Country, 2019 to 2034
Table 32: South Asia & Pacific Market US$ Mn Forecast by Drugs Type, 2019 to 2034
Table 33: South Asia & Pacific Market US$ Mn Forecast by Emetogenic Risk, 2019 to 2034
Table 34: South Asia & Pacific Market US$ Mn Forecast by Form, 2019 to 2034
Table 35: South Asia & Pacific Market US$ Mn Forecast by Distribution Channel, 2019 to 2034
Table 36: MEA Market US$ Mn Forecast by Country, 2019 to 2034
Table 37: MEA Market US$ Mn Forecast by Drugs Type, 2019 to 2034
Table 38: MEA Market US$ Mn Forecast by Emetogenic Risk, 2019 to 2034
Table 39: MEA Market US$ Mn Forecast by Form, 2019 to 2034
Table 40: MEA Market US$ Mn Forecast by Distribution Channel, 2019 to 2034
List Of Figures
Figure 01: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drugs Type, 2019 to 2034
Figure 02: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Emetogenic Risk, 2019 to 2034
Figure 03: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form, 2019 to 2034
Figure 04: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel, 2019 to 2034
Figure 05: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region, 2019 to 2034
Figure 06: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drugs Type, 2019 to 2034
Figure 07: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Emetogenic Risk, 2019 to 2034
Figure 08: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form, 2019 to 2034
Figure 09: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel, 2019 to 2034
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drugs Type, 2019 to 2034
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Emetogenic Risk, 2019 to 2034
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form, 2019 to 2034
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel, 2019 to 2034
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drugs Type, 2019 to 2034
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Emetogenic Risk, 2019 to 2034
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form, 2019 to 2034
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel, 2019 to 2034
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drugs Type, 2019 to 2034
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Emetogenic Risk, 2019 to 2034
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form, 2019 to 2034
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel, 2019 to 2034
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 26: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drugs Type, 2019 to 2034
Figure 27: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Emetogenic Risk, 2019 to 2034
Figure 28: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form, 2019 to 2034
Figure 29: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel, 2019 to 2034
Figure 30: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 31: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drugs Type, 2019 to 2034
Figure 32: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Emetogenic Risk, 2019 to 2034
Figure 33: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form, 2019 to 2034
Figure 34: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel, 2019 to 2034
Figure 35: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drugs Type, 2019 to 2034
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Emetogenic Risk, 2019 to 2034
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form, 2019 to 2034
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel, 2019 to 2034
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Chemotherapy Induced Nausea And Vomiting Treatment Market